Candel Therapeutics CADL announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to ...

Terumo Interventional Systems has announced the early commercial availability of its FDA-approved Roadsaver Carotid Stent ...

Compared to the previous generation of Olympus scopes, the technology provides improved visibility and less blurring, the ...

Olympus announced that it received FDA 510(k) clearance for its EZ1500 series endoscopes featuring Extended Depth of Field ...

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...

Hyperfine, Inc. (NASDAQ: HYPR), the company behind the world’s first FDA-cleared portable MRI system powered by artificial ...

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

Despite hiring a commercial chief and sponsoring disease awareness efforts last year, Savara will have to wait a while longer ...

Incyte INCY announced that the FDA has approved its new drug, Zynyz (retifanlimab-dlwr), a PD-1 inhibitor, for treating a new cancer indication. The regulatory body has now approved Zynyz in ...

"We are pleased to receive the FDA's approval of LED BLU-U and look forward to seeing the positive impact this next generation device will have for those living with actinic keratosis," said Abhay ...

(RTTNews) - Amneal Pharmaceuticals (AMRX) announced that the FDA has approved Brekiya injection, the first and only dihydroergotamine autoinjector for the acute treatment of migraine with or ...